|
The purpose of the draft guidance is to explain the new electronic copy (eCopy) program for medical device submissions. The draft guidance describes how FDA plans to implement the eCopy Program under the Federal Food, Drug,and Cosmetic Act (the FD&C Act).
|
Write a comment:
|